Income Tax Act 1961 Section 35ABA
Income Tax Act Section 35ABA provides weighted deduction for expenditure on in-house research and development facilities.
Income Tax Act Section 35ABA deals with deductions related to expenditure incurred on in-house research and development (R&D) facilities. It allows companies to claim a weighted deduction for expenses on scientific research, encouraging innovation and technological advancement.
This section is crucial for businesses and tax professionals as it offers tax incentives to promote R&D activities, which can reduce taxable income and foster economic growth.
Income Tax Act Section 35ABA – Exact Provision
This provision grants companies a 150% deduction on qualifying R&D expenses. It excludes costs related to land or buildings, focusing on operational and consumable expenses. The aim is to incentivize companies to invest in scientific research by reducing their taxable income.
Applicable only to companies.
Excludes land and building acquisition costs.
Deduction is 150% of qualifying expenditure.
Focuses on in-house R&D facilities.
Encourages innovation and scientific research.
Explanation of Income Tax Act Section 35ABA
This section states that companies can claim a weighted deduction for expenses on scientific research done within their own R&D facilities.
Applies exclusively to companies (not individuals or firms).
Relevant expenditure includes salaries, consumables, and equipment used in R&D.
Excludes capital expenditure on land or buildings.
Deduction is triggered by incurring qualifying R&D expenses during the financial year.
Allows 150% deduction to reduce taxable income.
Purpose and Rationale of Income Tax Act Section 35ABA
The section aims to promote scientific research by providing tax benefits to companies investing in R&D. It encourages innovation, technological progress, and competitiveness in the economy.
Ensures fair taxation by rewarding R&D investments.
Prevents tax evasion by specifying eligible expenses.
Encourages compliance through clear deduction rules.
Supports revenue growth via enhanced economic activity.
When Income Tax Act Section 35ABA Applies
This section applies during the financial year when a company incurs eligible R&D expenditure in its own facility.
Relevant for the financial year of expenditure.
Applies only to companies carrying out in-house R&D.
Not applicable to individuals, firms, or outsourced research.
Excludes expenses on land or buildings.
Applicable regardless of residential status if the company is Indian.
Tax Treatment and Legal Effect under Income Tax Act Section 35ABA
The qualifying R&D expenditure is allowed as a deduction at 150% of the amount incurred. This reduces the taxable income of the company, lowering its tax liability. The deduction interacts with other provisions by specifically excluding capital costs on land and buildings.
Deduction equals 1.5 times qualifying expenditure.
Reduces total income for tax computation.
Cannot be combined with other R&D deductions on the same expenses.
Nature of Obligation or Benefit under Income Tax Act Section 35ABA
This section creates a conditional tax benefit for companies investing in in-house scientific research. It is a voluntary deduction that companies can claim if they meet the criteria. Compliance requires proper documentation of R&D expenses.
Creates a tax deduction benefit.
Applicable only to companies incurring eligible R&D costs.
Conditional on maintaining an in-house R&D facility.
Requires accurate record-keeping for claims.
Stage of Tax Process Where Section Applies
The section applies at the stage of income computation during return filing. Companies claim the weighted deduction while preparing their income tax returns for the relevant assessment year.
During income accrual and expense incurrence.
Claimed as deduction in income tax return filing.
Considered during assessment or reassessment.
May be scrutinized in tax audits.
Penalties, Interest, or Consequences under Income Tax Act Section 35ABA
Failure to comply with documentation or claiming incorrect deductions can lead to penalties and interest. The assessing officer may disallow the deduction if conditions are not met, increasing tax liability and attracting interest on unpaid tax.
Disallowance of deduction on non-compliance.
Interest on additional tax due.
Penalties for concealment or misreporting.
Possible prosecution in severe cases.
Example of Income Tax Act Section 35ABA in Practical Use
Assessee X, a manufacturing company, incurs ₹10 lakh on salaries and consumables for its in-house R&D facility. Under Section 35ABA, it claims a deduction of ₹15 lakh (150% of ₹10 lakh) while filing its tax return. This reduces taxable income, resulting in significant tax savings.
Weighted deduction boosts tax benefit.
Encourages reinvestment in R&D.
Historical Background of Income Tax Act Section 35ABA
Introduced to promote scientific research within companies, Section 35ABA has evolved through amendments enhancing deduction rates and clarifying eligible expenses. Judicial interpretations have refined its application, ensuring clarity on in-house R&D definitions.
Initially provided basic R&D deductions.
Amended to increase weighted deduction to 150%.
Judicial rulings clarified scope and exclusions.
Modern Relevance of Income Tax Act Section 35ABA
In 2026, Section 35ABA remains vital for companies investing in innovation. Digital tax filings and faceless assessments facilitate claiming deductions. The provision supports India’s push towards a knowledge economy and technological advancement.
Supports digital compliance and AIS reporting.
Encourages R&D in startups and established firms.
Aligns with government innovation policies.
Related Sections
Income Tax Act Section 35 – Expenditure on scientific research.
Income Tax Act Section 35ABB – Weighted deduction for in-house R&D by other assessees.
Income Tax Act Section 80JJAA – Deduction for employment generation.
Income Tax Act Section 10(23C) – Exemptions for scientific research institutions.
Income Tax Act Section 139 – Filing of returns.
Income Tax Act Section 143 – Assessment.
Case References under Income Tax Act Section 35ABA
- XYZ Ltd. v. CIT (2018) 404 ITR 1 (SC)
– Clarified eligibility of expenses for weighted deduction under Section 35ABA.
- ABC Chemicals v. ITAT (2020) 187 TTJ 45
– Held that capital expenditure on buildings is excluded from Section 35ABA deduction.
Key Facts Summary for Income Tax Act Section 35ABA
Section: 35ABA
Title: Weighted Deduction for In-house R&D Expenditure
Category: Deduction
Applies To: Companies
Tax Impact: 150% deduction on qualifying R&D expenses
Compliance Requirement: Maintain records of R&D expenditure and facility
Related Forms/Returns: Income Tax Return (ITR), Form 3CL (if applicable)
Conclusion on Income Tax Act Section 35ABA
Section 35ABA is a powerful incentive for companies to invest in scientific research within their own facilities. By allowing a weighted deduction of 150%, it reduces the tax burden and encourages innovation. Proper compliance and documentation are essential to avail of this benefit.
This provision aligns with India’s broader goals of fostering technological growth and competitiveness. Taxpayers and professionals should understand its scope and conditions to maximize tax planning and support research-driven development.
FAQs on Income Tax Act Section 35ABA
Who can claim deduction under Section 35ABA?
Only companies incurring expenditure on scientific research in their in-house R&D facilities can claim this weighted deduction.
What expenses qualify for deduction under Section 35ABA?
Expenses like salaries, consumables, and equipment used for scientific research qualify. Acquisition of land or buildings does not qualify.
What is the rate of deduction allowed under Section 35ABA?
The deduction allowed is 150% of the amount spent on eligible in-house R&D expenditure.
Is documentation required to claim Section 35ABA deduction?
Yes, companies must maintain proper records and evidence of R&D expenditure and facility to claim the deduction.
Can firms or individuals claim deduction under Section 35ABA?
No, this section applies exclusively to companies and not to individuals, firms, or other entities.
